Correction to: Venetoclax for Treating Chronic Lymphocytic Leukaemia: An Evidence Review Group Perspective of a NICE Single Technology Appraisal

Overview of attention for article published in PharmacoEconomics, February 2019

Altmetric Badge

Mentioned by

twitter: 1 X user

facebook: 1 Facebook page

Readers on

mendeley: 3 Mendeley

Summary X Facebook

So far, Altmetric has seen 1 public wall post.

Healtheconbot, 19 Feb 2019

#HealthEconJA Correction to: Venetoclax for Treating Chronic Lymphocytic Leukaemia: An Evidence Review Group Perspective of a…